Related references
Note: Only part of the references are listed.17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: Relevance to Alzheimer's prevention
Liqin Zhao et al.
NEUROBIOLOGY OF AGING (2011)
Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma memebrane and in endocytic vesicles
Shuji Matsuda et al.
NEUROBIOLOGY OF AGING (2011)
The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid β-peptide (Aβ1-40): Implications for Bri2 effects on processing of amyloid precursor protein and Aβ aggregation
Siwei Peng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Peroxisome Proliferator-Activated Receptor Gamma Enhances the Activity of an Insulin Degrading Enzyme-Like Metalloprotease for Amyloid-beta Clearance
Ira Espuny-Camacho et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Insulin-Degrading Enzyme Sorting in Exosomes: A Secretory Pathway for a Key Brain Amyloid-beta Degrading Protease
Ayelen Bulloj et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Statins Promote the Degradation of Extracellular Amyloid β-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) Secretion
Irfan Y. Tamboli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Memory Deficits Due to Familial British Dementia BRI2 Mutation Are Caused by Loss of BRI2 Function Rather than Amyloidosis
Robert Tamayev et al.
JOURNAL OF NEUROSCIENCE (2010)
BRI2 homodimerizes with the involvement of intermolecular disulfide bonds
Maria Tsachaki et al.
NEUROBIOLOGY OF AGING (2010)
Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits
Robert Tamayev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease
Janaky Coomaraswamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis
Yvonne S. Eisele et al.
SCIENCE (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
PPARγ transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons
Jing Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Insulin-degrading enzyme is exported via an unconventional protein secretion pathway
Ji Zhao et al.
MOLECULAR NEURODEGENERATION (2009)
A beta-degrading enzymes in Alzheimer's disease
James Scott Miners et al.
BRAIN PATHOLOGY (2008)
BRI2 inhibits amyloid β-peptide precursor protein processing by interfering with the docking of secretases to the substrate
Shuji Matsuda et al.
JOURNAL OF NEUROSCIENCE (2008)
BRI2 (ITM2b) inhibits Aβ deposition in vivo
Jungsu Kim et al.
JOURNAL OF NEUROSCIENCE (2008)
Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b
Lucas Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-β-degrading enzyme neprilysin
Yvonne S. Eisele et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Rebecca Radde et al.
EMBO REPORTS (2006)
BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid β (Aβ) production
A Fotinopoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The familial dementia BRI2 gene binds the Alzheimer gene amyloid-β precursor protein and inhibits amyloid-β production
S Matsuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Insulin-degrading enzyme degrades amyloid peptides associated with British and Danish familial dementia
L Morelli et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
The role of cerebral amyloid β accumulation in common forms of Alzheimer disease
S Gandy
JOURNAL OF CLINICAL INVESTIGATION (2005)
Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: Implications for Alzheimer's disease intervention
LX Zhao et al.
JOURNAL OF NEUROSCIENCE (2004)
Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
MA Leissring et al.
NEURON (2003)
Aβ42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain
S Weggen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo
BC Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
BRICHOS:: a conserved domain in proteins associated with dementia, respiratory distress and cancer
L Sánchez-Pulido et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production
T Moehlmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
S Weggen et al.
NATURE (2001)
Metabolic regulation of brain Aβ by neprilysin
N Iwata et al.
SCIENCE (2001)
A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred
R Vidal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
